Log in to save to my catalogue

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinica...

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinica...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66b89bac42f44806ae6552cdfe03993b

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

About this item

Full title

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

Publisher

United States: John Wiley & Sons, Inc

Journal title

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2024-01, Vol.16 (1), p.e12504-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

INTRODUCTION
Establishing valid diagnostic strategies is a precondition for successful therapeutic intervention in Alzheimer's disease (AD).
METHODS
One hundred forty‐four healthy 75‐year‐old participants from the Vienna‐Transdanube‐Aging longitudinal cohort study were tested for neuroaxonal damage by single molecular array (Simoa) plasma...

Alternative Titles

Full title

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_66b89bac42f44806ae6552cdfe03993b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66b89bac42f44806ae6552cdfe03993b

Other Identifiers

ISSN

2352-8729

E-ISSN

2352-8729

DOI

10.1002/dad2.12504

How to access this item